Maria S. Adana-De
Malaga, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Response to the Letter by Zhang "The hidden variable in a 'neutral' upgrade: why parameter re-tuning and perceived reliability matter after G6 → G7 in Control-IQ".
Journal: Therapeutic advances in endocrinology and metabolism
Published: May 15, 2026
Prospective multicenter evaluation of glycemic and patient-reported outcomes following transition to a next-generation continuous glucose monitoring system in users of advanced hybrid closed-loop technology.
Journal: Therapeutic advances in endocrinology and metabolism
Published: March 30, 2025
Pharmaceutical targeting of the cannabinoid type 1 receptor impacts the crosstalk between immune cells and islets to reduce insulitis in humans.
Journal: Diabetologia
Published: March 01, 2024
Efficacy and safety of basal insulin degludec 100 IU/mL versus glargine 300 IU/mL for type 1 diabetes: The single-center INEOX randomized controlled trial.
Journal: Diabetes research and clinical practice
Published: July 15, 2022
Development and Validation of the Depression Inventory for Type 1 Diabetes (DID-1).
Journal: International journal of environmental research and public health
Published: September 16, 2021
Development and Preliminary Validation of a New Type 1 Diabetes Adjustment Scale (DAS-1).
Journal: Frontiers in psychology
Published: December 12, 2019
Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study.
Journal: Diabetes care
Published: April 12, 2019
Relationship between glucose control, glycemic variability, and oxidative stress in children with type 1 diabetes.
Journal: Endocrinologia, diabetes y nutricion
Published: September 06, 2018
Unilateral renal agenesis and abrupt onset diabetes: an unfrequent form of MODY type diabetes.
Journal: Medicina clinica
Published: December 21, 2017
Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease.
Journal: Diabetes research and clinical practice
Published: May 30, 2015
Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
Journal: Medicina clinica
Published: May 26, 2015
Last Updated: 09/26/2026